ACADVL Antikörper (AA 251-350) (Cy5)
Kurzübersicht für ACADVL Antikörper (AA 251-350) (Cy5) (ABIN708450)
Target
Alle ACADVL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 251-350
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human ACADVL
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- ACADVL (Acyl-CoA Dehydrogenase, Very Long Chain (ACADVL))
-
Andere Bezeichnung
- ACADVL
-
Hintergrund
-
Synonyms: ACAD 6, ACAD6, ACADV_HUMAN, Acadvl, Acyl CoA dehydrogenase very long chain, Acyl Coenzyme A dehydrogenase very long chain, LCACD, mitochondrial, Very long chain specic acyl CoA dehydrogenase, Very long chain specic acyl CoA dehydrogenase mitochondrial, Very long-chain specic acyl-CoA dehydrogenase, VLCAD.
Background: ACADVL (acyl-Coenzyme A dehydrogenase, very long chain) catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. It is specific to esters of long-chain and very long chain fatty acids such as palmitoyl-CoA and stearoyl-CoA. Deficiencies in ACADVL are associated with reduced myocardial fatty acid beta-oxidation and cardiomyopathy.
-
Gen-ID
- 37
-
Pathways
- ER-Nucleus Signaling, Monocarboxylic Acid Catabolic Process
Target
-